← Back to Search

Anti-inflammatory Sleeve

Reparel™ Knee Sleeve for Osteoarthritis

N/A

Waitlist Available

Led By Amit Momaya, MD

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

no corticosteroid knee injection for 90 days following consent

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial will study the eﬀects of Reparel™, an anti-inﬂammatory sleeve, on mobility, functionality, and pain in patients with knee osteoarthritis.

Who is the study for?

This trial is for individuals with knee osteoarthritis confirmed by radiograph, who haven't had corticosteroid injections in the past 90 days and are choosing non-surgical treatments. It's not for those with prior knee surgery, both knees affected, unstable knees on exam, cancer in the knee area or hardware in the knee.Check my eligibility

What is being tested?

The study tests if wearing a Reparel™ Knee Sleeve can improve mobility, function, and pain for people with knee osteoarthritis. The sleeve uses anti-inflammatory technology which might help manage symptoms of OA without drugs or surgery.See study design

What are the potential side effects?

Since this intervention involves wearing a special sleeve and does not involve medication or invasive procedures, side effects may be minimal but could include skin irritation or discomfort at the site where the sleeve is worn.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I haven't had a corticosteroid injection in my knee for the last 90 days.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Knee Injury and Osteoarthritis Outcome Score (KOOS)

Lysholm Score

Oxford Knee Score (OKS)

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Reparel Sleeve GroupExperimental Treatment1 Intervention

Patients receiving reparel knee sleeve for treatment of knee osteoarthritis.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,583 Previous Clinical Trials

2,279,984 Total Patients Enrolled

8 Trials studying Osteoarthritis

44,618 Patients Enrolled for Osteoarthritis

Amit Momaya, MDPrincipal InvestigatorUniversity of Alabama at Birmingham

2 Previous Clinical Trials

174 Total Patients Enrolled

1 Trials studying Osteoarthritis

74 Patients Enrolled for Osteoarthritis

Media Library

Reparel Knee Sleeve (Anti-inflammatory Sleeve) Clinical Trial Eligibility Overview. Trial Name: NCT04743921 — N/A

Osteoarthritis Research Study Groups: Reparel Sleeve Group

Osteoarthritis Clinical Trial 2023: Reparel Knee Sleeve Highlights & Side Effects. Trial Name: NCT04743921 — N/A

Reparel Knee Sleeve (Anti-inflammatory Sleeve) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04743921 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can anyone sign up for this experiment currently?

"The latest information from clinicaltrials.gov shows that this trial is no longer recruiting patients. The study's original posting was on July 1st, 2021 and the last update was on the same day, one year later. There are 728 other trials currently seeking patients if you're interested in participating in medical research."

Answered by AI